Search

You searched for "atrophy"

308 results found

In conversation with Robert MacLaren

2 December 2019 | EYE - Vitreo-Retinal, EYE - General
Professor Robert MacLaren gave the Keeler Lecture at the Royal College of Ophthalmologists Annual Meeting in May 2019 on gene therapy for retinitis pigmentosa. We caught up with him afterwards to find out more. What are the key messages of...

The eye without tears

1 June 2016 | | EYE - General
The Art is long and Life is short. So goes the dispiriting tag in Latin and flung from day one and at regular intervals thereafter at idle medical students who, inevitably brainwashed, come by graduation to believe that the only...

The approach to trabeculectomy postoperative complications

1 August 2016 | | EYE - Glaucoma
Performing a trabeculectomy is like giving birth to a baby. It may be traumatic and there is scope for devastating error but once the operation is completed only then does the real work begin. The bleb must be nurtured into...

My ophthalmology elective: Reflections from Singapore

4 August 2025 | | EYE - General
Why do an ophthalmology elective? An elective in ophthalmology can offer a unique opportunity to delve deeper into the highly competitive specialty beyond the confines of the medical school curriculum, while experiencing a healthcare system in a new cultural setting....

Crystalline keratopathy in monoclonal gammopathy of undetermined significance

2 April 2025 | | EYE - Cornea
Monoclonal gammopathies encompass a group of plasma cell disorders characterised by the excessive production of abnormal monoclonal immunoglobulins in the bloodstream [1]. This category includes multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), amyloidosis and other lymphoproliferative disorders. Monoclonal gammopathy...

Serendipity

3 October 2024 |
“Serendipity is looking in a haystack for a needle and discovering a farmer’s daughter” – Julius Comroe Jr (Surgeon, Medical Researcher and Author) One of the attractive features of ophthalmology, apart from the good quality of life and the relatively...

What's trending Aug/Sep 2024

2 August 2024 | | EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #GeneralElection #RightToVote It goes without saying that the general election has been dominating the headlines and with it, the challenges many...

On becoming a man

1 October 2018 | | EYE - Vitreo-Retinal, EYE - General
It was at the height of the gender debate, with Donald Trump banning transsexuals from serving in the US army and parts of the first world indulging in controversies on whether separate transgender toilets are needed, that a 40-year-old lady,...

Nanosecond laser cataract surgery

2 December 2019 | | EYE - Cataract, EYE - Refractive, EYE - General
The authors review the evidence for nanosecond laser cataract surgery: is this the future? Cataract is a leading cause of visual impairment worldwide, and cataract surgery is one of the most successful and cost-effective healthcare interventions, with a great impact...

The Leicester Grading System for Foveal Hypoplasia

1 April 2020 | | EYE - Paediatrics, EYE - Neuro-ophthalmology, EYE - Orbit, EYE - General
The University of Leicester Ulverscroft Eye Unit have published the first medical grading system named after the city of Leicester. Infantile nystagmus is characterised by constant and involuntary eye movements and affects 24 per 10,000 people [1]. Onset is usually...

DMEK vs. UT-DSAEK: has the debate been finally concluded?

1 October 2021 | | EYE - Cornea, EYE - General
In recent years the surgical treatment of corneal endothelial dystrophy has progressed tremendously. Descemet’s membrane endothelial keratoplasty (DMEK) is the newest iteration in the line of rapid surgical advances that has taken place. However, the previously accepted gold standard prior...

Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies

1 October 2018 | | EYE - General
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...